Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 16

    1.

    Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease.

    Sonnenberg A, Genta RM.

    Aliment Pharmacol Ther. 2012 Feb;35(4):469-76. doi: 10.1111/j.1365-2036.2011.04969.x. Epub 2012 Jan 5.

    PMID:
    22221289
    [PubMed - indexed for MEDLINE]
    2.

    Prevalence of non Helicobacter pylori species in patients presenting with dyspepsia.

    Yakoob J, Abbas Z, Khan R, Naz S, Ahmad Z, Islam M, Awan S, Jafri F, Jafri W.

    BMC Gastroenterol. 2012 Jan 6;12:3.

    PMID:
    22226326
    [PubMed - in process]
    Free PMC Article
    3.

    Gastric cancer development after Helicobacter pylori eradication therapy: a new form of gastric neoplasia.

    Matsuo T, Ito M, Tatsugami M, Boda T, Takata S, Tanaka S, Chayama K.

    Digestion. 2012;85(1):61-7. Epub 2012 Jan 5.

    PMID:
    22223100
    [PubMed - indexed for MEDLINE]
    4.

    The use of AlbuMAX II(®) as a blood or serum alternative for the culture of Helicobacter pylori.

    Hutton ML, Kaparakis-Liaskos M, Ferrero RL.

    Helicobacter. 2012 Feb;17(1):68-76. doi: 10.1111/j.1523-5378.2011.00914.x.

    PMID:
    22221619
    [PubMed - in process]
    5.

    Mucoid Helicobacter pylori isolates with fast growth under microaerobic and aerobic conditions.

    Siavoshi F, Saniee P, Atabakhsh M, Pedramnia S, Tavakolian A, Mirzaei M.

    Helicobacter. 2012 Feb;17(1):62-7. doi: 10.1111/j.1523-5378.2011.00913.x.

    PMID:
    22221618
    [PubMed - in process]
    6.

    Sociocultural and dietary practices among Malay subjects in the north-eastern region of Peninsular Malaysia: a region of low prevalence of Helicobacter pylori infection.

    Lee YY, Ismail AW, Mustaffa N, Musa KI, Majid NA, Choo KE, Mahendra Raj S, Derakhshan MH, Malaty HM, Graham DY.

    Helicobacter. 2012 Feb;17(1):54-61. doi: 10.1111/j.1523-5378.2011.00917.x.

    PMID:
    22221617
    [PubMed - in process]
    7.

    Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece.

    Georgopoulos S, Papastergiou V, Xirouchakis E, Laudi F, Papantoniou N, Lisgos P, Spiliadi C, Fragou P, Skorda L, Karatapanis S.

    Helicobacter. 2012 Feb;17(1):49-53. doi: 10.1111/j.1523-5378.2011.00911.x.

    PMID:
    22221616
    [PubMed - in process]
    8.

    A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.

    Fakheri H, Taghvaei T, Hosseini V, Bari Z.

    Helicobacter. 2012 Feb;17(1):43-8. doi: 10.1111/j.1523-5378.2011.00896.x.

    PMID:
    22221615
    [PubMed - in process]
    9.

    Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB.

    Rimbara E, Noguchi N, Kawai T, Sasatsu M.

    Helicobacter. 2012 Feb;17(1):36-42. doi: 10.1111/j.1523-5378.2011.00912.x.

    PMID:
    22221614
    [PubMed - in process]
    10.

    Inverse association between Helicobacter pylori and pediatric asthma in a high-prevalence population.

    Zevit N, Balicer RD, Cohen HA, Karsh D, Niv Y, Shamir R.

    Helicobacter. 2012 Feb;17(1):30-5. doi: 10.1111/j.1523-5378.2011.00895.x.

    PMID:
    22221613
    [PubMed - in process]
    11.

    Natural History of Helicobacter pylori infection in childhood: eight-year follow-up cohort study in an urban community in northeast of Brazil.

    Queiroz DM, Carneiro JG, Braga-Neto MB, Fialho AB, Fialho AM, Goncalves MH, Rocha GA, Rocha AM, Braga LL.

    Helicobacter. 2012 Feb;17(1):23-9. doi: 10.1111/j.1523-5378.2011.00894.x.

    PMID:
    22221612
    [PubMed - in process]
    12.

    Arginine 66 residue of Fur is required for the regulatory function of this protein in the acid adaptation mechanism of Helicobacter pylori.

    Toledo H, Villafaena C, Valenzuela M, López-Solís R.

    Helicobacter. 2012 Feb;17(1):16-22. doi: 10.1111/j.1523-5378.2011.00893.x.

    PMID:
    22221611
    [PubMed - in process]
    13.

    Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review.

    Lahner E, Persechino S, Annibale B.

    Helicobacter. 2012 Feb;17(1):1-15. doi: 10.1111/j.1523-5378.2011.00892.x.

    PMID:
    22221610
    [PubMed - in process]
    14.

    Recent safety concerns with proton pump inhibitors.

    Chen J, Yuan YC, Leontiadis GI, Howden CW.

    J Clin Gastroenterol. 2012 Feb;46(2):93-114. Review.

    PMID:
    22227731
    [PubMed - indexed for MEDLINE]
    15.

    Synbiotic (probiotic and ginger extract) loaded floating beads: a novel therapeutic option in an experimental paradigm of gastric ulcer.

    Singh PK, Kaur IP.

    J Pharm Pharmacol. 2012 Feb;64(2):207-17. doi: 10.1111/j.2042-7158.2011.01397.x. Epub 2011 Nov 28.

    PMID:
    22221096
    [PubMed - indexed for MEDLINE]
    16.

    Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials.

    Saad AM, Choudhary A, Bechtold ML.

    Scand J Gastroenterol. 2012 Feb;47(2):129-35. Epub 2012 Jan 10.

    PMID:
    22229305
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk